Clinical utility of newly developed highly purified human menopausal gonadotrophins: a randomized controlled trial.

导出原文传递

翻译打印收藏纠错

第一作者： Hwa Seon,Koo

第一单位： Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, South Korea.

作者： Hwa Seon,Koo ^[1] ; Hwang,Kwon ^[2] ; Doo Seok,Choi ^[3] ; Song,Han ^[4] ; Jung Youn,Seo ^[4] ; Kwang Moon,Yang ^[5]

作者单位： Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, South Korea. ^[1] Department of Obstetrics and Gynecology, CHA Fertility Center of Bundang CHA General Hospital, CHA University, Seongnam, South Korea. ^[2] Infertility Clinic, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. ^[3] Clinical Development Department, LG Life Science, Seoul, South Korea. ^[4] Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, South Korea. Electronic address: km1yang@naver.com. ^[5]

关键词 Gonadotropin-releasing hormone antagonist protocol Highly purified HMG In vitro fertilization Infertility Number of oocytes